Here Are Wednesday’s Top Wall Street Analyst Research Calls: The Gap, Genmab, Hilton Worldwide, Intuitive Surgical, Marriott International, Merck, Novo Nordisk, Okta, and More
24/7 Wall St. lists Wednesday analyst research calls. Upgrades include Hilton (HLT) to Buy with a $365 target, Intuitive Surgical (ISRG) to Outperform with a $500 target, Merck (MRK) to Outperform with a $143 target, and Okta (OKTA) to Outperform with a $170 target. Downgrades include The Gap (GAP) to Hold, and Novo Nordisk (NVO) to Hold. Initiations cover Genmab (GMAB) and Marriott (MAR).
How this was made
The 30-second read
Why it matters
The only time-critical macro disclosure is the scheduled CPI release at 8:30 AM EDT, which can rapidly change rates and risk appetite. The analyst changes can influence relative performance but are not primary fundamental catalysts in the text.
Market read
Traders get a watchlist of analyst rating changes across consumer, healthcare, software, and industrials, but the macro CPI release is the main near-term driver.
What to watch
The article provides no new company fundamentals (earnings, guidance, trial data). Any trade should be sized for macro volatility around CPI and rates.
Background
The piece is a multi-name roundup of analyst upgrades, downgrades, and initiations, wrapped in a pre-market macro and rates context ahead of July CPI.
Ticker impact
Hilton Worldwide was upgraded to Buy from Hold by Deutsche Bank, with a $365 target price cited in the article.
Mild positive bias for the session, with follow-through depending on broader risk-off/off CPI reaction.
The article provides an explicit rating change and target, but it is still analyst-driven rather than a fundamental disclosure.
Intuitive Surgical was raised to Outperform from Perform at Oppenheimer, with a $500 target price mentioned.
Moderately positive near-term drift versus peers, unless macro data triggers broad de-risking.
The catalyst is clear (upgrade and target), but the text lacks any new company-specific operational data.
Merck was upgraded to Outperform from Neutral at Daiwas, with a $143 target price included.
Slightly positive reaction potential, likely capped by macro uncertainty.
The article discloses a concrete rating/target change, but not earnings, guidance, or trial updates.
Okta was raised to Outperform from Market Perform at Citizens, with a $170 target price cited.
Short-term upside bias, with volatility risk around the CPI release.
Clear analyst action and target, but no new product, contract, or guidance details are provided.
Genmab was initiated with an Outperform rating at BNP Paribas, with a $40 target price mentioned.
Potential early positive drift, fading if macro turns risk-off.
The article provides initiation and target only; no new clinical or commercial catalyst is described.
Marriott International was initiated with an Outperform rating at CICC, with a $410 target price cited.
Mild positive bias, likely sensitive to rates and consumer-demand expectations.
Initiation and target are disclosed, but the article lacks any new bookings, guidance, or operational data.
Mercury Systems was started with an Overweight rating at Piper Sandler, with a $126 target price mentioned.
Low-to-moderate positive drift, contingent on defense/aerospace sentiment and macro tape.
The text contains only rating initiation and target, with no new backlog or program award details.
Monolithic Power Systems was initiated with a Buy rating at GF Securities, with a $1,706 target price cited.
Potential short-term upside bias, especially if tech holds up post-CPI.
The article discloses initiation and target only, without any new order, guidance, or product milestone.
Market effects
CPI risk is the dominant cross-asset driver; analyst calls mainly affect relative performance within sectors.
US-focused analyst notes, but the article also flags renewed US-Iran tensions that can spill into energy and risk sentiment.
Macro inflation expectations can move global rates, impacting growth and defensives simultaneously; energy and gold are also discussed.
Counterpoint
Analyst upgrades and downgrades may be quickly overwhelmed by CPI-driven rate repricing, making single-name follow-through unreliable.
Key entities
- macro_releaseJuly CPI (scheduled)
July consumer price index is scheduled for 8:30 AM EDT, with economists forecasting headline and core increases.
- equityHilton Worldwide
Upgraded to Buy from Hold by Deutsche Bank with a $365 target cited.
- equityThe Gap
Downgraded to Hold from Buy by Jefferies with target cut to $23 from $29.
